HI
ARCT icon

Harbour Investments’s Arcturus Therapeutics ARCT Stock Holding History

Harbour Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211 Buy
31
+18
+138% +$142 ﹤0.01% 4540
2026
Q1 		$104 Buy
+13
New +$95 ﹤0.01% 4500
2021
Q4 		– Sell
-218
Closed -$10K – 2662
2021
Q3 		$10K Buy
218
+7
+3% +$314 ﹤0.01% 2644
2021
Q2 		$7K Sell
211
-221
-51% -$7.48K ﹤0.01% 2884
2021
Q1 		$18K Buy
+432
New +$25.8K ﹤0.01% 2260

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Harbour Investments's ARCT Position: Q2 2026 in Review

Harbour Investments increased its Arcturus Therapeutics (ARCT) stake by 138% in Q2 2026, buying an estimated $142 and bringing the position to 31 shares worth $211. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

Harbour Investments first reported a position in ARCT in Q1 2021 and has held it in 5 quarters since. The position peaked at $18K in Q1 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Harbour Investments held 31 shares of Arcturus Therapeutics worth $211 as of Q2 2026.
  • Harbour Investments bought 18 Arcturus Therapeutics shares in Q2 2026, an estimated $142.
  • Arcturus Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4540 holding.
  • Harbour Investments first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Arcturus Therapeutics position peaked at $18K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.